The global burden of chronic respiratory disease in adults

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 1, 2015, Pages 10-20

  Burney, P ^a   Jarvis, D ^a   Perez Padilla, R ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Asthma; Chronic respiratory diseases; Low income

Indexed keywords

STEROID;

AGING; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ADMINISTRATION ROUTE; DRUG USE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG CANCER; MORTALITY; NOMENCLATURE; PASSIVE SMOKING; PREVALENCE; PUBLIC HEALTH; RISK FACTOR; SMOKING; STEROID THERAPY; WHEEZING; WORKMAN COMPENSATION; ADULT; ADVERSE EFFECTS; AFRICA; ASIA; CHRONIC DISEASE; COST OF ILLNESS; EUROPE; INCOME; INHALATIONAL DRUG ADMINISTRATION; MIDDLE EAST; POVERTY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION DISORDERS;

ADMINISTRATION, INHALATION; ADULT; AFRICA; ASIA; ASTHMA; CHRONIC DISEASE; COST OF ILLNESS; EUROPE; HUMANS; INCOME; MIDDLE EAST; POVERTY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION DISORDERS; RISK FACTORS; SMOKING; STEROIDS;

EID: 84918817960     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.14.0446     Document Type: Article

References (92)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD. Bethesda, MD, USA: GOLD, 2011.
2. Swanney M P, Ruppel G, Enright P L, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008;63:1046-1051.
3. Hansen J, Sun X G, Wasserman K. Ethnic- and sex-free formulae for detection of airway obstruction. Am Rev Respir Crit Care Med 2006;174:493-498.
4. Pedone C, Scarlata S, Chiurco D, Conte M E, Forastiere F, Antonelli-Incalzi R. Association of reduced total lung capacity with mortality and use of health services. Chest 2012;141:1025-1030.
5. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-968.
6. Tan W, Vollmer W, Lamprecht B, Mannino D, et al. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax 2012;67:718-726.
7. Higgins B G, Britton J R, Chinn S, Cooper S, Burney P, Tattersfield A. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiological studies. Am Rev Respir Dis 1992;145:588-593.
8. Holland W W, Ashford J R, Colley J R T, Morgan D C, Pearson N J. A comparison of two respiratory symptoms questionnaires. Br J Prev Soc Med 1966;20:76-96.
9. Gupta R, Perez-Padilla R, Marks G, Vollmer W, Menezes A, Burney P. Summarising published results from spirometric surveys of COPD: the problem of inconsistent definitions. Int J Tuberc Lung Dis 2014;18:998-1003.
10. Buist A S, Vollmer W M, Sullivan S D, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2:277-283.
11. Menezes A M, Perez-Padilla R, Jardim J R, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.[see comment]. Lancet 2005;366:1875-1881.
12. Hankinson J L, Odencrantz J R, Fedan K B. Spirometric reference values from a sample of the general U. S.population. Am Rev Respir Crit Care Med 1999;159:179-187.
13. Burney P, Jithoo A, Kato B, et al. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty - a BOLD analysis. Thorax 2014;69:465-473.
14. Burney P G J, Hooper R J. The use of ethnically specific norms for ventilatory function in African-American and white populations. Int J Epidemiol 2012;41:782-790.
15. Braun L, Wolfgang M, Dickersin K. Defining race/ethnicity and explaining difference in research studies on lung function. Eur Respir J 2013;41:1362-1370.
16. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic. Lancet 2013;380:2095-2128.
17. Burney P G J, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011;66:49-54.
18. Astemborski J A, Beaty T H, Cohen B H. Variance components analysis of forced expiration in families. Am J Med Genet 1985;21:741-753
19. Fried L P, Kronmal R A, Newman A B, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998;279:585-592.
20. Marks G, Burney P. Diseases of the respiratory system. In: Charlton J, ed. The health of adult Britain: 1841-1994. In: Murphy C J, ed. The health of adult Britain 1841-1994. London, UK: Her Majesty's Stationery Office, 1997.
21. Adair T, Hoy D, Dettrick Z, Lopez A D. 100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuber Lung Dis 2012;16:1699-1705.
22. Erbas B, Ullah S, Hyndman R J, Scollo M, Abramson M. Forecasts of COPD mortality in Australia: 2006-2025. BMC Med Res Methodol 2012;12:17.
23. Xu X, Laird N, Dockery D W, Schouten J P, Rijcken B, Weiss S T. Age, period, and cohort effects on pulmonary function in a 24-year longitudinal study. Am J Epidemiol 1995;141:554.
24. Salomon J, Wang H, Freeman M, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 2012;380:2144-2162.
25. Murray C J L, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-2223.
26. Buist A S, McBurnie M A, Vollmer W M, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-750.
27. Hooper R, Burney P, Vollmer W, et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J 2012;39:1343-1353.
28. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 1976;2:1525.
29. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519-1528.
30. Salvi S, Barnes P. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733-743.
31. Smith M, Li L, Augustyn M, et al. Prevalence and correlates of airflow obstruction in 317, 000 never-smokers in China. Eur Respir J 2014;44:66-77.
32. Spix C, Anderson H R, Schwartz J, et al. Short-term effects of air pollution on hospital admissions of respiratory diseases in Europe: a quantitative summary of APHEA study results. Arch Environ Health 1998;53:54-64.
33. Atkinson R W, Anderson H R, Sunyer J, et al. Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Am Rev Respir Crit Care Med 2001;164:1860-1866.
34. Holland W W, Reid D D. The urban factor in chronic bronchitis. Lancet 1965;285:445-500.
35. Schikowski T, Adam M, Marcon A, et al. Association of ambient air pollution with the prevalence and incidence of COPD. Eur Respir J 2014;44:614-626.
36. Blanc P D, Eisner M D, Balmes J R, Trupin L, Yelin E H, Katz P P. Exposure to vapors, gas, dust, or fumes: assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. Am J Ind Med 2005;48:110-117.
37. Blanc P D, Iribarren C, Trupin L, et al. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax 2009;64:6-12.
38. Menezes A M B, Hallal P C, Perez-Padilla R, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J 2007;30:1180-1185.
39. Carey I M, Strachan D P, Cook D G. Effects of changes in fresh fruit consumption on ventilatory function in healthy British adults. Am J Respir Crit Care Med 1998;158:728-733.
40. Butland B K, Fehily A M, Elwood P C. Diet, lung function, and lung function decline in a cohort of 2512 middle aged men. Thorax 2000;55:102-108.
41. McKeever T M, Lewis S A, Smit H A, Burney P, Cassano P A, Britton J. A multivariate analysis of serum nutrient levels and lung function. Respir Res 2008;9:67.
42. McKeever T, Lewis S, Cassano P, et al. Patterns of dietary intake and relation to respiratory disease, forced expiratory volume in 1 s, and decline in 5-y forced expiratory volume. Am J Clin Nutr 2010;92:408.
43. Shaheen S O, Jameson K A, Syddall H E, et al. The relationship of dietary patterns with adult lung function and COPD. Eur Respir J 2010;36:277-284.
44. McKeever T, Lewis S, Smit H, Burney P, Cassano P, Britton J. A multivariate analysis of serum nutrient levels and lung function. Respir Res 2008;9:67.
45. Burrows B, Bloom J W, Traver G A, Cline M G. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987;317:1309-1347.
46. Obaseki D, Potts J, Joos G, Baelum J, Haahtela T. The relation of airway obstruction to asthma, chronic rhinosinusitis and age: results from a population survey of adults. Allergy 2014;69:1205-1214.
47. Quanjer P, Stanojevic S, Cole T, et al. Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324-1343
48. Hooper R, Burney P. Cross-sectional relation of ethnicity to ventilatory function in a West London population. Int J Tuberc Lung Dis 2013;17:400-405.
49. Harik-Khan R I, Fleg J L, Muller D C, Wise R A. The effect of anthropometric and socioeconomic factors on the racial difference in lung function. Am Rev Respir Crit Care Med 2001;164:1647.
50. Obeidat M, Wain L V, Shrine N, Kalsheker N, Artigas M S. A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample. PLOS ONE 2011;6:e19382.
51. Hegewald M, Crapo R. Socio-economic status and lung function. Chest 2007;132:1608-1614.
52. Barker D J P, Godfrey K M, Fall C, Osmond C, Winter P D, Shaheen S O. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991;303:671-675.
53. Lawlor D A, Ebrahim S, Davey S G. Association of birth weight with adult lung function: findings from the British Women's Heart and Health Study and a meta-analysis. [Review] Thorax 2005;60:851-858.
54. Canoy D, Pekkanen J, Elliott P, et al. Early growth and adult respiratory function in men and women followed from the fetal period to adulthood. Thorax 2007;62:396-402.
55. Pei L, Chen G, Mi J, et al. Low birth weight and lung function in adulthood: retrospective cohort study in china, 1948-1996. Pediatrics 2010;125:e899-e905.
56. Okubo H, Shaheen S O, Ntani G, et al. Processed meat consumption and lung function: Modification by antioxidants and smoking. Eur Respir J 2014;43:972-982.
57. Holland W W. European Community atlas of avoidable death. Oxford, UK: Oxford University Press, 1988.
58. Mohan G, Harrison B D W, Badminton R M. A confidential enquiry into deaths caused by asthma in an English health region: implications for general practice. Br J Gen Pract 1996;46:529-532.
59. Bucknall C E, Slack R, Godley C C, Mackay T W, Wright S C. Scottish confidential inquiry into asthma deaths (SCIAD), 1994-6. Thorax 1999;54:978-984.
60. Royal College of Physicians. Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report. London, UK: RCP, 2014.
61. Burney P, Chinn S, Jarvis D, Luczynska C, Lai E. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687-695.
62. Sembajwe G, Cifuentes M, Tak S W, Kriebel D, Gore R, Punnett L. National income, self-reported wheezing and asthma diagnosis from the World Health Survey. Eur Respir J 2010;35:279.
63. Jarvis D, Luczynska C, Chinn S, et al. Change in prevalence of IgE sensitization and mean total IgE with age and cohort. J Allergy Clin Immunol 2005;116:675-682.
64. Law M, Morris J K, Wald N, Luczynska C, Burney P. Changes in atopy over a quarter of a century, based on cross sectional data at three time periods. BMJ 2005;330:1187-1188.
65. Ekerljung L, Andersson A, Sundblad B M, et al. Has the increase in the prevalence of asthma and respiratory symptoms reached a plateau in Stockholm, Sweden? Int J Tuberc Lung Dis 2010;14:764-771.
66. Bjerg A, Ekerljung L, Middelveld R, et al. Increased prevalence of symptoms of rhinitibut not of asthma between 1990 s and 2008 in Swedish adults: comparisons of the ECRHS and GA (2) LEN surveys. PLOS ONE 2011;6:e16082.
67. Backman H, Hedman L, Jansson S A, Lindberg A, Lundback B, Ronmark E. Prevalence trends in respiratory symptoms and asthma in relation to smoking: two cross-sectional studies ten years apart among adults in northern Sweden. World Allergy Organ J 2014;7:1-10.
68. Chinn S, Jarvis D, Burney P, Luczynska C, et al. Increase in diagnosed asthma but not in symptoms in the European Community Respiratory Health Survey. Thorax 2004;59:646-651.
69. Janson C, Kunzli N, de Marco R, et al. Changes in active and passive smoking in the European Community Respiratory Health Survey. Eur Respir J 2006;27:517-524.
70. de Marco R, Cappa V, Accordini S, et al. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J 2012;39:883-892.
71. Moffatt M, Gut I, Demenais F, et al. A large-scale, consortiumbased genomewide association study of asthma. N Engl J Med 2010;363:1211.
72. Sibbald B, Turner-Warwick M. Factors influencing the prevalence of asthma among first degree relatives of extrinsic and intrinsic asthmatics. Thorax 1979;34:332-337.
73. Sibbald B, Horn M E, Brain E A, Gregg I. Genetic factors in childhood asthma. Thorax 1980;35:671-674.
74. Longo G, Strinati R, Poli F, Fumi F. Genetic factors in nonspecific bronchial hyperreactivity. Am J Dis Child 1987;141:331-334.
75. Pinart M, Benet M, Annesi-Maesano I, von Berg A, Berdel D, Carlsen K C L. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med 2014;2:131-140.
76. Braback L, Hedberg A. Perinatal risk factors for atopic disease in conscripts. Clin Exp Allergy 1998;28:936-942.
77. Svanes C, Omenaas E, Gulsvik A, Jarvis D, Chinn S, Burney P. Early exposure to children in family and day care as related to adult asthma and hay fever: results from the European Community Respiratory Health Survey. Thorax 2002;57:945-950.
78. Strachan D. Hay fever, hygiene, and household size. BMJ 1989;299:1259-1260.
79. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001;358:1129-1133.
80. Leynaert B, Neukirch C, Jarvis D, Chinn S, Burney P, Neukirch F. Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am J Respir Crit Care Med 2001;164:1829-1834.
81. Lampi J, Canoy D, Jarvis D, et al. Farming environment and prevalence of atopy at age 31: prospective birth cohort study in Finland. Clin Exp Allergy 2011;41:987-993.
82. Merrett T, Merrett J, Cookson J. Allergy and parasites; the measurement of total and specific IgE levels in urban and rural communities in Rhodesia. Clin Allergy 1976;6:131-134.
83. Calvert J, Burney P. Ascaris, atopy, and exercise-induced bronchoconstriction in rural and urban South African children. J Allergy Clin Immunol 2010;125:100-105.
84. Haahtela T, Holgate S, Pawankar R, et al. The biodiversity hypothesis and allergic disease: World Allergy Organization position statement. World Allergy Organ J 213;6:3.
85. Godfrey R C, Gradidge C F. Allergic sensitization of human lung fragments prevented by saturation of IgE binding sites. Nature 1976;259:484-486.
86. van den Biggelaar A H J, van Ree R, Rodrigues L C, et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000;356:1723-1727.
87. Feary J, Britton J, Leonardi-Bee J. Atopy and current intestinal parasite infection: a systematic review and meta-analysis. Allergy 2011;66:569-578.
88. Feary J R, Venn A J, Mortimer K, et al. Experimental hookworm infection: A randomized placebo-controlled trial in asthma. Clin Exp Allergy 2010;40:299-306.
89. Lynch N R, Hagel I A, Palenque M E, et al. Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment. J Allergy Clin Immunol 1998;101(2 Pt 1):217-221.
90. Kogevinas M, Anto J M, Sunyer J, et al. Occupational asthma in Europe and other industrialised areas: a population-based study. Lancet 1999;353:1750-1754.
91. Kogevinas M, Zock J P, Jarvis D, et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 2007;370:336-341.
92. Zock J P, Plana E, Jarvis D, et al. The use of household cleaning sprays and adult asthma: an international longitudinal study. Am Rev Respir Crit Care Med 2007;176:735-741.